{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:44:15Z","timestamp":1776987855437,"version":"3.51.4"},"reference-count":35,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.1210\/jc.2010-0504","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T13:38:00Z","timestamp":1278509880000},"page":"3103-3110","source":"Crossref","is-referenced-by-count":16,"title":["Approach to the Patient with Type 2 Diabetes and Progressive Kidney Disease"],"prefix":"10.1210","volume":"95","author":[{"given":"Elizabeth R.","family":"Seaquist","sequence":"first","affiliation":[{"name":"Divisions of Endocrinology and Diabetes (E.R.S.), Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan N.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Renal Diseases and Hypertension (H.N.I.), Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113472329900_R1","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1523-1755.2005.00265.x","article-title":"Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?","volume":"67","author":"Jones","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113472329900_R2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.","volume":"321","author":"Stratton","year":"2000","journal-title":"Brit Med J"},{"key":"key\n\t\t\t\t2019041113472329900_R4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes\u2014UK Prospective Diabetes Study 74.","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113472329900_R6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00125-005-0077-3","article-title":"Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.","volume":"49","author":"Rossing","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113472329900_R7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.numecd.2007.05.006","article-title":"Importance of glycemic control on the course of glomerular filtration rate in type 2 diabetes with hypertension and microalbuminuria under tight blood pressure control.","volume":"18","author":"Thomaseth","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key\n\t\t\t\t2019041113472329900_R8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus.","volume":"329","author":"Shamoon","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R10","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes.","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R11","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/archinte.163.21.2594","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus\u2014systematic review and meta-analysis.","volume":"163","author":"Salpeter","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113472329900_R12","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113472329900_R13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.0894-0959.2004.17346.x","article-title":"Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.","volume":"17","author":"Snyder","year":"2004","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t2019041113472329900_R14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2125.2007.02890.x","article-title":"Effect of renal impairment on the pharmacokinetics of exenatide.","volume":"64","author":"Linnebjerg","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041113472329900_R15","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/dc06-2545","article-title":"Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.","volume":"30","author":"Bergman","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113472329900_R16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5414\/CPP41492","article-title":"Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.","volume":"41","author":"Czock","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113472329900_R17","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.2215\/CJN.04090609","article-title":"Hypertension goals in advanced stage kidney disease","volume":"4","author":"Hopkins","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113472329900_R18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events.","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R19","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113472329900_R20","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy.","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.CIR.0000012918.84068.43","article-title":"Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.","volume":"105","author":"Sacks","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113472329900_R23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113472329900_R24","first-page":"S125","article-title":"Hypercholesterolemia\u2014a determinant of renal-function loss and deaths in IDDM patients with nephropathy","volume":"45","author":"Krolewski","year":"1994","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t2019041113472329900_R25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ki.5001515","article-title":"Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.","volume":"70","author":"Tonolo","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113472329900_R26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R27","doi-asserted-by":"crossref","first-page":"C115","DOI":"10.1159\/000163844","article-title":"Critiques of Clinical Guidelines in Nephrology: Anaemia","volume":"110","author":"Courtney","year":"2008","journal-title":"Nephron Clinical Practice"},{"key":"key\n\t\t\t\t2019041113472329900_R28","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472329900_R29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Gutie\u0301rrez","year":"2008","journal-title":"N Engl J Med"},{"issue":"1 Suppl","key":"key\n\t\t\t\t2019041113472329900_R30","first-page":"S1","article-title":"annual data report","volume":"53","author":"Collins","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041113472329900_R31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQI (TM)) conference.","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113472329900_R32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-6143.2009.02566.x","article-title":"Kidney and pancreas transplantation in the United States, 1998\u20132007: access for patients with diabetes and end-stage renal disease.","volume":"9","author":"McCullough","year":"2009","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019041113472329900_R33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1600-6143.2008.02173.x","article-title":"Kidney and pancreas transplantation in the United States, 1997\u20132006: the HRSA breakthrough collaboratives and the 58 DSA challenge.","volume":"8","author":"Leichtman","year":"2008","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019041113472329900_R34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"UK Prospective Diabetes Study 16\u2014overview of 6 years therapy of type-II diabetes, a progressive disease.","volume":"44","author":"Turner","year":"1995","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113472329900_R35","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status.","volume":"20","author":"Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/7\/3103\/9066154\/jcem3103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:31:15Z","timestamp":1559237475000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/7\/3103\/2596220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0504","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}